News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
457,402 Results
Type
Article (28494)
Company Profile (125)
Press Release (428783)
Multimedia
Podcasts (29)
Webinars (10)
Section
Business (123865)
Career Advice (1500)
Deals (24805)
Drug Delivery (61)
Drug Development (58949)
Employer Resources (66)
FDA (10920)
Job Trends (9869)
News (221203)
Policy (19681)
Tag
Academia (1492)
Accelerated approval (21)
Adcomms (10)
Allergies (90)
Alliances (27289)
ALS (115)
Alzheimer's disease (1059)
Antibody-drug conjugate (ADC) (185)
Approvals (11223)
Artificial intelligence (248)
Autoimmune disease (88)
Automation (16)
Bankruptcy (196)
Best Places to Work (7903)
BIOSECURE Act (5)
Biosimilars (108)
Biotechnology (90)
Bladder cancer (125)
Brain cancer (33)
Breast cancer (476)
Cancer (3412)
Cardiovascular disease (257)
Career advice (1299)
Career pathing (16)
CAR-T (184)
CDC (17)
Cell therapy (489)
Cervical cancer (22)
Clinical research (51273)
Collaboration (871)
Company closure (3)
Compensation (592)
Complete response letters (28)
COVID-19 (1742)
CRISPR (52)
C-suite (385)
Cystic fibrosis (112)
Data (4864)
Decentralized trials (2)
Denatured (2)
Depression (97)
Diabetes (332)
Diagnostics (4152)
Digital health (22)
Diversity (5)
Diversity, equity & inclusion (16)
Drug discovery (124)
Drug pricing (94)
Drug shortages (10)
Duchenne muscular dystrophy (161)
Earnings (65924)
Editorial (35)
Employer branding (12)
Employer resources (66)
Events (74990)
Executive appointments (475)
FDA (13085)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (13)
Funding (771)
Gene editing (120)
Generative AI (19)
Gene therapy (372)
GLP-1 (624)
Government (2459)
Grass and pollen (4)
Guidances (361)
Healthcare (11784)
HIV (41)
Huntington's disease (23)
IgA nephropathy (65)
Immunology and inflammation (149)
Immuno-oncology (27)
Indications (67)
Infectious disease (1914)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (75)
Intellectual property (166)
Interviews (241)
IPO (13153)
IRA (31)
Job creations (2272)
Job search strategy (1105)
Kidney cancer (14)
Labor market (54)
Layoffs (319)
Leadership (14)
Legal (4245)
Liver cancer (50)
Longevity (8)
Lung cancer (477)
Lymphoma (290)
Machine learning (18)
Management (21)
Manufacturing (399)
MASH (119)
Medical device (8257)
Medtech (8282)
Mergers & acquisitions (12503)
Metabolic disorders (827)
Multiple sclerosis (117)
NASH (12)
Neurodegenerative disease (184)
Neuropsychiatric disorders (49)
Neuroscience (1835)
NextGen: Class of 2025 (3678)
Non-profit (2463)
Now hiring (23)
Obesity (358)
Opinion (128)
Ovarian cancer (127)
Pain (134)
Pancreatic cancer (144)
Parkinson's disease (176)
Partnered (17)
Patents (323)
Patient recruitment (292)
Peanut (37)
People (28475)
Pharmaceutical (27)
Pharmacy benefit managers (9)
Phase I (15423)
Phase II (22451)
Phase III (17496)
Pipeline (3377)
Policy (130)
Postmarket research (2096)
Preclinical (6268)
Press Release (57)
Prostate cancer (164)
Psychedelics (29)
Radiopharmaceuticals (183)
Rare diseases (532)
Real estate (3587)
Recruiting (33)
Regulatory (15690)
Reports (22)
Research institute (1317)
Resumes & cover letters (234)
Rett syndrome (20)
RNA editing (4)
RSV (50)
Schizophrenia (104)
Series A (120)
Series B (80)
Service/supplier (6)
Sickle cell disease (62)
Special edition (16)
Spinal muscular atrophy (126)
Sponsored (24)
Startups (1950)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (48)
The Weekly (26)
Vaccines (611)
Venture capital (46)
Weight loss (230)
Women's health (45)
Worklife (7)
Date
Today (6)
Last 7 days (89)
Last 30 days (1179)
Last 365 days (21928)
2026 (19)
2025 (21944)
2024 (24416)
2023 (26936)
2022 (33208)
2021 (36174)
2020 (34451)
2019 (28211)
2018 (20921)
2017 (19862)
2016 (18369)
2015 (22366)
2014 (15906)
2013 (11867)
2012 (12790)
2011 (13757)
2010 (12092)
Location
Africa (565)
Alabama (68)
Alaska (1)
Arizona (182)
Arkansas (4)
Asia (25611)
Australia (4235)
California (7602)
Canada (1937)
China (701)
Colorado (290)
Connecticut (346)
Delaware (241)
Europe (59621)
Florida (1192)
Georgia (232)
Idaho (26)
Illinois (564)
India (39)
Indiana (380)
Iowa (16)
Japan (271)
Kansas (83)
Kentucky (18)
Louisiana (16)
Maine (70)
Maryland (874)
Massachusetts (5240)
Michigan (146)
Minnesota (353)
Mississippi (5)
Missouri (67)
Montana (13)
Nebraska (7)
Nevada (82)
New Hampshire (37)
New Jersey (2372)
New Mexico (7)
New York (2165)
North Carolina (978)
North Dakota (3)
Northern California (3733)
Ohio (199)
Oklahoma (8)
Oregon (13)
Pennsylvania (1601)
Puerto Rico (16)
Rhode Island (23)
South America (752)
South Carolina (44)
South Dakota (1)
Southern California (2974)
Tennessee (101)
Texas (1240)
United States (27182)
Utah (223)
Vermont (1)
Virginia (178)
Washington D.C. (50)
Washington State (672)
West Virginia (4)
Wisconsin (53)
Wyoming (2)
457,402 Results for "10".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
COVID-19
Prasad’s Claim of 10 Pediatric Deaths From COVID-19 Shots Overblown: Report
The FDA’s Vinay Prasad recently claimed in an internal memo that at least 10 children have died from coronavirus vaccines, but an internal safety review showed that the count was much lower.
December 15, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
Last week, Center for Biologics Evaluation and Research Director Vinay Prasad claimed in an internal memo—without providing evidence—that COVID-19 vaccines were responsible for the deaths of 10 children between 2021 and 2024.
December 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Biodexa Announces Pricing of $10 Million Public Offering
December 19, 2025
·
5 min read
Press Releases
Cue Biopharma Announces Pricing of $10 Million Public Offering
December 22, 2025
·
5 min read
Press Releases
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase - December 10, 2025
December 11, 2025
·
1 min read
Clinical Research
Terns Climbs 10% As ‘Unprecedented’ Leukemia Data Beats Novartis’ Scemblix
TERN-701 more than doubled the response rate of Novartis’ rival approved therapy in an early-stage trial, sending the biotech’s shares flying.
December 9, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
December 2, 2025
·
5 min read
Now Hiring
10 Companies Hiring in San Francisco
Looking for a biopharma job in San Francisco? Check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
May 15, 2025
·
2 min read
·
Angela Gabriel
Press Releases
NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS
December 17, 2025
·
5 min read
1 of 45,741
Next
